Trial intelligence / Profile preview

BEFIRTH: ATG Induction in HCV Liver Transplant

NCT00538265Phase 4Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
May 2005
Primary completion
Jan 2010
Countries
1
01

Overview

A Phase 4 trial of antithymocyte globulin rabbit in liver transplantation, hepatitis C (HCV), sponsored by Centre hospitalier universitaire de Toulouse. Started May 2005; status: completed.

02

Drugs

antithymocyte globulin rabbit
03

Conditions

liver transplantationhepatitis C (HCV)

Beyond the preview

Go deeper on NCT00538265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00538265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call